DNAPrint Genomics Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
DNAG has 1.29 billion shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 1.29B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +11.77% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.09% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.17
| Current Ratio | 0.17 |
| Quick Ratio | 0.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.24 |
| Interest Coverage | -4.19 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -105.00% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 77.59% |
| Revenue Per Employee | 77,248 |
| Profits Per Employee | -182,032 |
| Employee Count | 25 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 6.12 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 92.57 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 42.64 |
| Average Volume (20 Days) | 15,559 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.59 |
Income Statement
In the last 12 months, DNAG had revenue of 1.93 million and -4.55 million in losses. Loss per share was -0.01.
| Revenue | 1.93M |
| Gross Profit | 446,369 |
| Operating Income | -6.31M |
| Pretax Income | -4.55M |
| Net Income | -4.55M |
| EBITDA | -5.78M |
| EBIT | -6.31M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 134,347 in cash and 5.33 million in debt, giving a net cash position of -5.19 million or -0.00 per share.
| Cash & Cash Equivalents | 134,347 |
| Total Debt | 5.33M |
| Net Cash | -5.19M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -8.39M |
| Book Value Per Share | -0.01 |
| Working Capital | -9.35M |
Cash Flow
In the last 12 months, operating cash flow was -4.14 million and capital expenditures -164,998, giving a free cash flow of -4.31 million.
| Operating Cash Flow | -4.14M |
| Capital Expenditures | -164,998 |
| Free Cash Flow | -4.31M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 23.11%, with operating and profit margins of -326.54% and -235.64%.
| Gross Margin | 23.11% |
| Operating Margin | -326.54% |
| Pretax Margin | -235.64% |
| Profit Margin | -235.64% |
| EBITDA Margin | -299.11% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DNAG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -74.44% |
| Shareholder Yield | -74.44% |
| Earnings Yield | -351,412.66% |
| FCF Yield | -332,497.92% |
Stock Splits
The last stock split was on July 12, 2005. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jul 12, 2005 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
DNAG has an Altman Z-Score of -30.23. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -30.23 |
| Piotroski F-Score | n/a |